Drug recall D-0441-2024
Product
NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03
Reason for recall
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
Lots and codes
Lot #, 1990305, Exp 08-31-2025
Recall details
- Recalling firm
- Esperion, Ann Arbor, MI
- Quantity
- 3,480 30-count bottles
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 27, 2024
Related products
- Nexlizet – drug information
- NDC 72426-818 Nexlizet · Bempedoic Acid 180 mg/1; Ezetimibe 10 mg/1 · Esperion Therapeutics, Inc.